Skip to main content
Erschienen in: International Journal of Hematology 5/2019

08.03.2019 | Original Article

A synonymous splice site mutation in IL2RG gene causes late-onset combined immunodeficiency

verfasst von: Motoi Yamashita, Ryosuke Wakatsuki, Tamaki Kato, Tsubasa Okano, Shingo Yamanishi, Nobuko Mayumi, Mayuri Tanaka, Yumi Ogura, Hirokazu Kanegane, Shigeaki Nonoyama, Kohsuke Imai, Tomohiro Morio

Erschienen in: International Journal of Hematology | Ausgabe 5/2019

Einloggen, um Zugang zu erhalten

Abstract

X-Linked severe combined immunodeficiency (X-SCID) is a severe form of primary immunodeficiency characterized by absence of T cells and NK cells. X-SCID is caused by a loss-of-function mutation in the IL2RG gene that encodes common gamma chain (γc), which plays an essential role in lymphocyte development. We report the first case of hypomorphic X-SCID caused by a synonymous mutation in the IL2RG gene leading to a splice anomaly, in a family including two patients with diffuse cutaneous warts, recurrent molluscum contagiosum, and mild respiratory infections. The mutation caused aberrant splicing of IL2RG mRNA, subsequently resulted in reduced γc expression. The leaky production of normally spliced IL2RG mRNA produced undamaged protein; thus, T cells and NK cells were generated in the patients. Functional assays of the patients’ T cells and NK cells revealed diminished cytokine response in the T cells and absent cytokine response in the NK cells. In addition, the TCR repertoire in these patients was limited. These data suggest that a fine balance between aberrant splicing and leaky production of normally spliced IL2RG mRNA resulted in late-onset combined immunodeficiency in these patients.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Kwan A, Abraham RS, Currier R, Brower A, Andruszewski K, Abbott JK, et al. Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States. JAMA. 2014;312:729–38.CrossRefPubMedPubMedCentral Kwan A, Abraham RS, Currier R, Brower A, Andruszewski K, Abbott JK, et al. Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States. JAMA. 2014;312:729–38.CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Noguchi M, Yi H, Rosenblatt HM, Filipovich AH, Adelstein S, Modi WS, et al. Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans. Cell. 1993;73:147–57.CrossRefPubMed Noguchi M, Yi H, Rosenblatt HM, Filipovich AH, Adelstein S, Modi WS, et al. Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans. Cell. 1993;73:147–57.CrossRefPubMed
3.
Zurück zum Zitat Puck JM, Deschênes SM, Porter JC, Dutra AS, Brown CJ, Willard HF, et al. The interleukin-2 receptor γ chain maps to Xq13.1 and is mutated in X-linked severe combined immunodeficiency, SCIDX1. Hum Mol Genet. 1993;2:1099–104.CrossRefPubMed Puck JM, Deschênes SM, Porter JC, Dutra AS, Brown CJ, Willard HF, et al. The interleukin-2 receptor γ chain maps to Xq13.1 and is mutated in X-linked severe combined immunodeficiency, SCIDX1. Hum Mol Genet. 1993;2:1099–104.CrossRefPubMed
4.
5.
Zurück zum Zitat Gray PEA, Logan GJ, Alexander IE, Poulton S, Roscioli T, Ziegler J. A novel intronic splice site deletion of the IL-2 receptor common gamma chain results in expression of a dysfunctional protein and T-cell-positive X-linked Severe combined immunodeficiency. Int J Immunogenet. 2015;42:11–4.CrossRefPubMed Gray PEA, Logan GJ, Alexander IE, Poulton S, Roscioli T, Ziegler J. A novel intronic splice site deletion of the IL-2 receptor common gamma chain results in expression of a dysfunctional protein and T-cell-positive X-linked Severe combined immunodeficiency. Int J Immunogenet. 2015;42:11–4.CrossRefPubMed
6.
Zurück zum Zitat Ginn SL, Smyth C, Wong M, Bennetts B, Rowe PB, Alexander IE. A novel splice-site mutation in the common gamma chain (gammac) gene IL2RG results in X-linked severe combined immunodeficiency with an atypical NK + phenotype. Hum Mutat. 2004;23:522–3.CrossRefPubMed Ginn SL, Smyth C, Wong M, Bennetts B, Rowe PB, Alexander IE. A novel splice-site mutation in the common gamma chain (gammac) gene IL2RG results in X-linked severe combined immunodeficiency with an atypical NK + phenotype. Hum Mutat. 2004;23:522–3.CrossRefPubMed
7.
Zurück zum Zitat Okuno Y, Hoshino A, Muramatsu H, Kawashima N, Wang X, Yoshida K, et al. Late-onset combined immunodeficiency with a novel IL2RG mutation and probable revertant somatic Mosaicism. J Clin Immunol. 2015;35:610–4.CrossRefPubMed Okuno Y, Hoshino A, Muramatsu H, Kawashima N, Wang X, Yoshida K, et al. Late-onset combined immunodeficiency with a novel IL2RG mutation and probable revertant somatic Mosaicism. J Clin Immunol. 2015;35:610–4.CrossRefPubMed
8.
Zurück zum Zitat Hsu AP, Pittaluga S, Martinez B, Rump AP, Raffeld M, Uzel G, et al. IL2RG reversion event in a common lymphoid progenitor leads to delayed diagnosis and milder phenotype. J Clin Immunol. 2015;35:449–53.CrossRefPubMedPubMedCentral Hsu AP, Pittaluga S, Martinez B, Rump AP, Raffeld M, Uzel G, et al. IL2RG reversion event in a common lymphoid progenitor leads to delayed diagnosis and milder phenotype. J Clin Immunol. 2015;35:449–53.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Kuijpers TW, van Leeuwen EMM, Barendregt BH, Klarenbeek P, aan de Kerk DJ, Baars PA, et al. A reversion of an IL2RG mutation in combined immunodeficiency providing competitive advantage to the majority of CD8 + T cells. Haematologica. 2013;98:1030–8.CrossRefPubMedPubMedCentral Kuijpers TW, van Leeuwen EMM, Barendregt BH, Klarenbeek P, aan de Kerk DJ, Baars PA, et al. A reversion of an IL2RG mutation in combined immunodeficiency providing competitive advantage to the majority of CD8 + T cells. Haematologica. 2013;98:1030–8.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Kawai T, Saito M, Nishikomori R, Yasumi T, Izawa K, Murakami T, et al. Multiple reversions of an IL2RG mutation restore T cell function in an X-linked severe combined immunodeficiency patient. J Clin Immunol. 2012;32:690–7.CrossRefPubMed Kawai T, Saito M, Nishikomori R, Yasumi T, Izawa K, Murakami T, et al. Multiple reversions of an IL2RG mutation restore T cell function in an X-linked severe combined immunodeficiency patient. J Clin Immunol. 2012;32:690–7.CrossRefPubMed
11.
Zurück zum Zitat Speckmann C, Pannicke U, Wiech E, Schwarz K, Fisch P, Friedrich W, et al. Clinical and immunologic consequences of a somatic reversion in a patient with X-linked severe combined immunodeficiency. Blood. 2008;112:4090–7.CrossRefPubMed Speckmann C, Pannicke U, Wiech E, Schwarz K, Fisch P, Friedrich W, et al. Clinical and immunologic consequences of a somatic reversion in a patient with X-linked severe combined immunodeficiency. Blood. 2008;112:4090–7.CrossRefPubMed
12.
Zurück zum Zitat Kamae C, Nakagawa N, Sato H, Honma K, Mitsuiki N, Ohara O, et al. Common variable immunodeficiency classification by quantifying T-cell receptor and immunoglobulin κ-deleting recombination excision circles. J Allergy Clin Immunol. 2013;131:1437–40.e5.CrossRefPubMed Kamae C, Nakagawa N, Sato H, Honma K, Mitsuiki N, Ohara O, et al. Common variable immunodeficiency classification by quantifying T-cell receptor and immunoglobulin κ-deleting recombination excision circles. J Allergy Clin Immunol. 2013;131:1437–40.e5.CrossRefPubMed
13.
Zurück zum Zitat Okano T, Tsujita Y, Kanegane H, Mitsui-Sekinaka K, Tanita K, Miyamoto S, et al. Droplet digital PCR-based chimerism analysis for primary immunodeficiency diseases. J Clin Immunol. 2018;38:300–6.CrossRefPubMed Okano T, Tsujita Y, Kanegane H, Mitsui-Sekinaka K, Tanita K, Miyamoto S, et al. Droplet digital PCR-based chimerism analysis for primary immunodeficiency diseases. J Clin Immunol. 2018;38:300–6.CrossRefPubMed
14.
Zurück zum Zitat Fuchs S, Rensing-Ehl A, Erlacher M, Vraetz T, Hartjes L, Janda A, et al. Patients with T+/low NK+ IL-2 receptor γ chain deficiency have differentially-impaired cytokine signaling resulting in severe combined immunodeficiency. Eur J Immunol. 2014;44:3129–40.CrossRefPubMed Fuchs S, Rensing-Ehl A, Erlacher M, Vraetz T, Hartjes L, Janda A, et al. Patients with T+/low NK+ IL-2 receptor γ chain deficiency have differentially-impaired cytokine signaling resulting in severe combined immunodeficiency. Eur J Immunol. 2014;44:3129–40.CrossRefPubMed
15.
Zurück zum Zitat Mella P, Imberti L, Brugnoni D, Pirovano S, Candotti F, Mazzolari E, et al. Development of autologous T lymphocytes in two males with X-linked severe combined immune deficiency: molecular and cellular characterization. Clin Immunol. 2000;95:39–50.CrossRefPubMed Mella P, Imberti L, Brugnoni D, Pirovano S, Candotti F, Mazzolari E, et al. Development of autologous T lymphocytes in two males with X-linked severe combined immune deficiency: molecular and cellular characterization. Clin Immunol. 2000;95:39–50.CrossRefPubMed
16.
17.
Zurück zum Zitat Stepensky P, Keller B, Shamriz O, Spee-Mayer von C, Friedmann D, Shadur B, et al. T + NK + IL-2 Receptor γ Chain Mutation: a Challenging Diagnosis of Atypical Severe Combined Immunodeficiency. J Clin Immunol. 2018;38:527–36.CrossRefPubMed Stepensky P, Keller B, Shamriz O, Spee-Mayer von C, Friedmann D, Shadur B, et al. T + NK + IL-2 Receptor γ Chain Mutation: a Challenging Diagnosis of Atypical Severe Combined Immunodeficiency. J Clin Immunol. 2018;38:527–36.CrossRefPubMed
18.
Zurück zum Zitat Niemela JE, Puck JM, Fischer RE, Fleisher TA, Hsu AP. Efficient detection of thirty-seven new IL2RG mutations in human X-linked severe combined immunodeficiency. Clin Immunol. 2000;95:33–8.CrossRefPubMed Niemela JE, Puck JM, Fischer RE, Fleisher TA, Hsu AP. Efficient detection of thirty-seven new IL2RG mutations in human X-linked severe combined immunodeficiency. Clin Immunol. 2000;95:33–8.CrossRefPubMed
19.
Zurück zum Zitat Puck JM, Pepper AE, Henthorn PS, Candotti F, Isakov J, Whitwam T, et al. Mutation analysis of IL2RG in human X-linked severe combined immunodeficiency. Blood. 1997;89:1968–77.PubMed Puck JM, Pepper AE, Henthorn PS, Candotti F, Isakov J, Whitwam T, et al. Mutation analysis of IL2RG in human X-linked severe combined immunodeficiency. Blood. 1997;89:1968–77.PubMed
20.
Zurück zum Zitat Sahashi K, Masuda A, Matsuura T, Shinmi J, Zhang Z, Takeshima Y, et al. In vitro and in silico analysis reveals an efficient algorithm to predict the splicing consequences of mutations at the 5′ splice sites. Nucleic Acids Res. 2007;35:5995–6003.CrossRefPubMedPubMedCentral Sahashi K, Masuda A, Matsuura T, Shinmi J, Zhang Z, Takeshima Y, et al. In vitro and in silico analysis reveals an efficient algorithm to predict the splicing consequences of mutations at the 5′ splice sites. Nucleic Acids Res. 2007;35:5995–6003.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Desmet F-O, Hamroun D, Lalande M, Collod-Béroud G, Claustres M, Béroud C. Human Splicing Finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res. 2009;37:e67.CrossRefPubMedPubMedCentral Desmet F-O, Hamroun D, Lalande M, Collod-Béroud G, Claustres M, Béroud C. Human Splicing Finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res. 2009;37:e67.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Mazzolari E, Forino C, Guerci S, Imberti L, Lanfranchi A, Porta F, et al. Long-term immune reconstitution and clinical outcome after stem cell transplantation for severe T-cell immunodeficiency. J Allergy Clin Immunol. 2007;120:892–9.CrossRefPubMed Mazzolari E, Forino C, Guerci S, Imberti L, Lanfranchi A, Porta F, et al. Long-term immune reconstitution and clinical outcome after stem cell transplantation for severe T-cell immunodeficiency. J Allergy Clin Immunol. 2007;120:892–9.CrossRefPubMed
23.
Zurück zum Zitat Marini A, Niehues T, Stege H, Ruzicka T, Hengge UR. Plantar warts in twins after successful bone marrow transplantation for severe combined immunodeficiency. J Dtsch Dermatol Ges. 2006;4:417–20.CrossRefPubMed Marini A, Niehues T, Stege H, Ruzicka T, Hengge UR. Plantar warts in twins after successful bone marrow transplantation for severe combined immunodeficiency. J Dtsch Dermatol Ges. 2006;4:417–20.CrossRefPubMed
24.
Zurück zum Zitat Grier JT, Forbes LR, Monaco-Shawver L, Oshinsky J, Atkinson TP, Moody C, et al. Human immunodeficiency-causing mutation defines CD16 in spontaneous NK cell cytotoxicity. J Clin Invest. 2012;122:3769–80.CrossRefPubMedPubMedCentral Grier JT, Forbes LR, Monaco-Shawver L, Oshinsky J, Atkinson TP, Moody C, et al. Human immunodeficiency-causing mutation defines CD16 in spontaneous NK cell cytotoxicity. J Clin Invest. 2012;122:3769–80.CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Orange JS. Human natural killer cell deficiencies and susceptibility to infection. Microbes Infect. 2002;4:1545–58.CrossRefPubMed Orange JS. Human natural killer cell deficiencies and susceptibility to infection. Microbes Infect. 2002;4:1545–58.CrossRefPubMed
Metadaten
Titel
A synonymous splice site mutation in IL2RG gene causes late-onset combined immunodeficiency
verfasst von
Motoi Yamashita
Ryosuke Wakatsuki
Tamaki Kato
Tsubasa Okano
Shingo Yamanishi
Nobuko Mayumi
Mayuri Tanaka
Yumi Ogura
Hirokazu Kanegane
Shigeaki Nonoyama
Kohsuke Imai
Tomohiro Morio
Publikationsdatum
08.03.2019
Verlag
Springer Japan
Erschienen in
International Journal of Hematology / Ausgabe 5/2019
Print ISSN: 0925-5710
Elektronische ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-019-02619-9

Weitere Artikel der Ausgabe 5/2019

International Journal of Hematology 5/2019 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.